American College of Surgeons Commission on

Cancer Quality Care Core Measures

The Pearlman Cancer Center consistently exceeds compliance rates as set forth by the American College of Surgeons Commission on Cancer. We are committed to providing the best cancer care available in South Georgia and North Florida.

Site

Measure

Benchmark

Percentage of SGMC/PCCC cases which meet core measurement

Breast

Radiation is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conservation surgery for breast cancer.

90%

93.75%

Tamoxifen or third generation aromatase inhibitor is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC Stage T1c or stage IB-III hormone receptor positive breast cancer.

90%

96.72%

Radiation therapy is recommended or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with >/= 4 positive regional lymph nodes.

90%

97.78%

Image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast.

80%

94.84%

Colon

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.

85%

97.94%

Lung

Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or lymph node-positive (pN1) and (pN2) non-small cell lung cancer.

85%

90.91%

Surgery is not the first course of treatment for cN2, M0 lung cases

85%

90.24%

Rectum

Preoperative chemotherapy and radiation are administered for clinical AJCC T3N0, T4N0, or Stage III; or postoperative chemotherapy and radiation are administered within 180 days of diagnosis for clinical AJCC T1-T2 with pathologic AJCC T3N0, T4N0, or Stage III; or treatment is recommended; for patients under the age of 80 receiving resection for rectal cancer.

85%

94.12%